Results 131 to 140 of about 5,317,329 (303)

A novel quinazolinone insulin receptor inhibitor and its synergy with an EGFR inhibitor in glucose‐driven glioblastoma

open access: yesMolecular Oncology, EarlyView.
The novel styrylquinazolinone‐based molecule W1B effectively suppresses glioblastoma by inhibiting IGF1R and EGFR. In high‐glucose microenvironments driving tumor resistance, W1B acts synergistically with the EGFR inhibitor dacomitinib. This combination safely blocks compensatory survival signaling in zebrafish xenograft models. Showcasing promising in
Patryk Rurka   +9 more
wiley   +1 more source

Lake Maurice, South Australia [cartographic material].

open access: yes, 1942
1st ed. Relief shown by form lines and spot heights.; "This map is compiled from the latest Commonwealth and State information and is not the result of precise military survey"; "This map is an official document.
Australia. Army. Survey Corps.
core  

Oncogenic DMTF1β promotes cancer cell motility by regulating autophagy through ULK1 stabilization

open access: yesMolecular Oncology, EarlyView.
In the current study, we demonstrate that the oncogene DMTF1β regulates ULK1 stability by reducing its proteasomal degradation in cancer cells. This stabilization enables ULK1 to induce autophagy, which in turn facilitates cancer cell migration. Consequently, reduced DMTF1β levels lead to decreased autophagy and impaired cancer cell migration.
Jun Xu   +13 more
wiley   +1 more source

Oodnadatta, South Australia [cartographic material].

open access: yes, 1941
1st ed. Shows telephone and power lines, electric power stations, roads, railways and aerodromes.; Relief shown by hachures and spot heights.; "This map is compiled from the latest Commonwealth and State information and is not the result of precise ...
Australia. Army. Survey Corps.
core  

Rational use of intensive care beds in Turkey: Point prevalence survey study

open access: yes
Objective: The limitation or withdrawal of futile treatment is widely accepted in the intensive care and medical ethics literature. However, implementing this in clinical practice is often difficult. The aim of the study is to understand the situation of
Demirag, Kubilay   +6 more
core   +1 more source

PAK1 activation drives divergent resistance mechanisms to aromatase inhibition and tamoxifen in a luminal: A breast cancer model

open access: yesMolecular Oncology, EarlyView.
Breast cancer remains a major cause of cancer death in women, frequently developing endocrine therapy resistance. This study demonstrates that upregulated p21‐activated kinase 1 (PAK1) activity drives resistance to tamoxifen and long‐term estrogen deprivation in ER+ breast cancer models.
Luisa Schwarzmüller   +10 more
wiley   +1 more source

Ireland 1:250,000 series : [cartographic material] Ordnance Survey holiday map /

open access: yes, 1980
Various eds. Tourist map series of Ireland showing international and county boundaries, roads, railways, water features, buildings and populated places.
Ordnance Survey (Ireland).
core  

Inhibition of cyclin‐dependent kinases 12/13 using CT7439 as a treatment for colorectal cancer with CDK12 upregulation

open access: yesMolecular Oncology, EarlyView.
The proposed mechanism of action for the CDK12/13 inhibitor and cyclin K degrader, CT7439. CDK12/13 inhibition interrupts transcription elongation, leading to increased DNA damage that results in cell death. This agent is a potentially novel treatment option for patients with colorectal cancer. Created in BioRender. Cyclin‐dependent kinase (CDK) 12 and
Wylie K. Watlington   +10 more
wiley   +1 more source

Innamincka, South Australia [cartographic material].

open access: yes, 1942
1st ed. Shows telephone and power lines, electric power stations, roads, railways and aerodromes.; Relief shown by land forms, form lines and spot heights.; "This map is compiled from the latest Commonwealth and State information and is not the result of
Australia. Army. Survey Corps.
core  

In vitro and in silico modelling of ROS1‐positive non‐small cell lung cancer reveals fusion‐dependent tyrosine kinase inhibitor responses

open access: yesMolecular Oncology, EarlyView.
Drug resistance limits treatment success in a subset of lung cancers driven by ROS1 gene alterations. Using patient‐derived cells and computer simulations, we studied three key mutations and how they affect five targeted drugs. The mutations reduced drug effectiveness in different ways by altering protein structure and behavior.
Farhan Ul Haq   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy